Brief: Endo USA Nationwide Recall of One Lot of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Lot Number 550147301 Due to Mislabeling
July 16 (Reuters) - Endo Inc NDOI.PK :
* ENDO USA, INC. ISSUES VOLUNTARY, NATIONWIDE RECALL OF ONE
LOT OF
CLONAZEPAM ORALLY DISINTEGRATING TABLETS, USP (C-IV) LOT NUMBER
550147301 DUE TO MISLABELING: INCORRECT STRENGTH ON PRODUCT
CARTON
* ENDO INC - TO DATE, HAS NOT RECEIVED REPORTS OF ADVERSE
EVENTS
ASSOCIATED WITH RECALLED LOT OF CLONAZEPAM ORALLY DISINTEGRATING
TABLETS
Source text for Eikon: ID:nPn3TYtPma
Further company coverage: NDOI.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Endo
See all newsBrief: Mallinckrodt, Endo Announce Planned Leadership Team For Merged Company
Brief: Endo To Report First Quarter 2025 Financial Results On May 7, 2025
Deals of the day-Mergers and acquisitions
Corrected: Deals of the day-Mergers and acquisitions
To Pay Endo $80.2 Million Termination Fee If Deal Is Terminated Under Certain Conditions